×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

FCB unit to win $30 mil biotech acc't

Published on .

Biotech company Amgen is expected to award an estimated $30 million direct-to-consumer account to FCB Worldwide's FCB Healthcare, New York. FCB will handle creative and media for Neupogen, a drug that helps fight infection after chemotherapy. An Amgen spokesman said the company is in final talks with FCB. FCB declined to comment.

Copyright July 2000, Crain Communications Inc.

In this article:
Most Popular